Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial

Publication Date

2019

Journal Title

J Clin Psychiatry

Volume Number

80

Issue Number

3

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Psychiatry

Additional Departments

Molecular Medicine

PMID

31050233

DOI

10.4088/JCP.18m12546

For the public and Northwell Health campuses

Share

COinS